CGC

Canopy Growth Corp

NasdaqAdd to watchlist

Healthcare · Drug Manufacturers—Specialty & Generic

$0.93

−$0.00−0.53%

Delayed · 2026-09-18T20:00:00.000Z · marketstack

21 open-market sales on file ($415K), none of them under a pre-arranged plan. Who, and when

Aug 24, 2026$0.93

−$0.12−11.05%over 1M

Session

Day range65% of range

$0.92$0.94

Fundamentals

Visualize fundamentals and more

Market cap: 394.39M
P/E ratio: -

Revenue grew +5.80% in FY2027, +3.06% slower than its sector. The median across Healthcare companies this platform tracks is +8.87%.

Risk factors, year on year

Item 1AJun 2026 10-KMay 2025

added: 67
dropped: 81
re-drafted: 58

Out of 265 passages in this year’s Item 1A.

New this year

We have concluded that certain of our previously issued financial statements should not be relied upon and have restated certain of our previously issued financial statements which was time-consuming and expensive and could expose us to additional risks that …

147 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add

What it says it is exposed to

From Item 1A of its most recent 10-K, filed June 2026.

Litigation
Data privacy
Product recalls
Goodwill impairment
Going concern
Tariffs
Export controls
Supply chain

And 15 more.

Litigation
Putative class action lawsuits alleging violations of securities laws may be filed against the Company and members of its management following our announcement that the Company had determined that it is appropriate to restate the Prior Financial Statements, …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

22 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Sep 18, 2026 · the last close

Canopy Growth Corp investor relations

What CGC has filed with the SEC. This is not Canopy Growth Corp’s own investor relations site: these filings are the primary source that site publishes from.

Companies like Canopy Growth Corp

Also filed under Drug Manufacturers, ranked by how closely they sit beside CGC.

LLYELI LILLY & Cocompare with CGC
JNJJohnson & Johnsoncompare with CGC
AMGNAmgen Inc.

MRKMerck & Co., Inc.compare with CGC

BMYBristol Myers Squibb Co.compare with CGC

Ask about Canopy Growth Corp

The assistant answers from what CGC has actually filed: 10 annual reports filed with the SEC and 29 Form 4 filings from the last year. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Press one and the answer appears right here on the page, from CGC's filings and figures. One a day without an account; a free account has its own, and no card.

See how much of Canopy Growth Corp each of these investors holds, and every quarter they moved.

Ten seconds. No card. Nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with Canopy Growth Corp

Be told the moment a CGC insider trades
Put Canopy Growth Corp on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Canopy Growth Corp's income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Canopy Growth Corp's fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

What it says it is exposed to

From Item 1A of its most recent 10-K, filed June 2026.

Litigation
Data privacy
Product recalls
Goodwill impairment
Going concern
Tariffs
Export controls
Supply chain

And 15 more.

Litigation
Putative class action lawsuits alleging violations of securities laws may be filed against the Company and members of its management following our announcement that the Company had determined that it is appropriate to restate the Prior Financial Statements, …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Risk factors, year on year

Item 1AJun 2026 10-KMay 2025

added: 67
dropped: 81
re-drafted: 58

Out of 265 passages in this year’s Item 1A.

New this year

We have concluded that certain of our previously issued financial statements should not be relied upon and have restated certain of our previously issued financial statements which was time-consuming and expensive and could expose us to additional risks that …

147 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add